Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model
نویسندگان
چکیده
منابع مشابه
Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global threat. The only approved vaccine against TB, Mycobacterium bovis bacillus Calmette-Guérin (BCG), provides insufficient protection and, being a live vaccine, can cause disseminated disease in immunocompromised individuals. Previously, we found that intradermal cDNA tattoo immunization with cDNA of tetanus toxoid fra...
متن کاملMonoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model
Background: Pancreatic carcinoma is the fourth-leading cause of cancer death in the United States and due to its late presentation, only few patients would be candidates for the curative treatment of pancreactomy. Monoclonal antibodies have brought hope to targeted therapy.Objectives: To identify new biomarkers, a panel of monoclonal antibodies was genera...
متن کاملSimultaneous Immunization against Tuberculosis
BACKGROUND BCG, the only licensed vaccine against tuberculosis, provides some protection against disseminated disease in infants but has little effect on prevention of adult pulmonary disease. Newer parenteral immunization prime boost regimes may provide improved protection in experimental animal models but are unproven in man so that there remains a need for new and improved immunization strat...
متن کاملHistory of Immunization against Tuberculosis
The isolation and cultivation of the tubercle bacillus by R. Kocli gave a great impetus to the efforts to immunize susceptible animals against tuberculosis. The methods of vaccination successfully used in a certain number of bacterial infections were naturally seized upon so as to arrive at the same results in this disease. The discovery of tuberculin by Koch led people to hope that it would be...
متن کاملComparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.
Methodologies for preclinical animal model testing of drugs against Mycobacterium tuberculosis vary from laboratory to laboratory; however, it is unknown if these variations result in different outcomes. Thus, a series of head-to-head comparisons of drug regimens in three commonly used mouse models (intravenous, a low-dose aerosol, and a high-dose aerosol infection model) and in two strains of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Immunology
سال: 2017
ISSN: 1664-3224
DOI: 10.3389/fimmu.2017.01744